Icyitegererezo cyo Kurekura Reagent
Izina RY'IGICURUZWA
Macro & Micro-Ikigereranyo Icyitegererezo Kurekura Reagent
Icyemezo
CE, FDA, NMPA
Ibice nyamukuru
| Izina | Ibice nyamukuru | IbigizeIbisobanuro | Umubare |
| Icyitegererezoreagent | Dithiothreitol, sodium dodecylsulfate (SDS), Inhibitor ya RNase,amazi meza, meza | 0.5mL / Vial | 50 Vial |
Icyitonderwa: Ibigize mubice bitandukanye byibikoresho ntibishobora guhinduka.
Imiterere yo kubika hamwe nubuzima bwubuzima
Kubika no gutwara ubushyuhe bwicyumba.Ubuzima bwo kubaho ni amezi 24.
Ibikoresho bikoreshwa
Ibikoresho nibikoresho mugihe cyo gutunganya icyitegererezo, nka pipeti, kuvanga vortex,kwiyuhagira amazi, nibindi
Icyitegererezo gisabwa
Ikusanyirizo rishya rya oropharyngeal swabs, nasopharyngeal swabs.
Icyitonderwa
Iyo iki gikoresho gikoreshwa mugukuramo munzu yuzuye neza CV kuri 10 ikoporora, coefficient de variable (CV,%) ya Ct agaciro ntabwo irenze 10%.
Itandukaniro hagati
Iyo mu nzu isobanutse neza igeragezwa mubice bitatu byibikoresho bigeragezwa nyuma yo kuyikuramo inshuro nyinshi, kandi, coefficente yo guhinduka (CV,%) yagaciro ka Ct ntabwo irenze 10%.
Kugereranya imikorere
Gukuramo neza
| Kugereranya neza uburyo bwa magneti yamashanyarazi nuburyo bwo gusohora icyitegererezo | ||||
| kwibanda | uburyo bwa rukuruzi | icyitegererezo | ||
| orfab | N | orfab | N | |
| 20000 | 28.01 | 28.76 | 28.6 | 29.15 |
| 2000 | 31.53 | 31.9 | 32.35 | 32.37 |
| 500 | 33.8 | 34 | 35.25 | 35.9 |
| 200 | 35.25 | 35.9 | 35.83 | 35.96 |
| 100 | 36.99 | 37.7 | 38.13 | Kureka |
Gukuramo neza kwicyitegererezo cyo gusohora byari bisa nuburyo bwa magnetiki yamasaro, kandi kwibanda kwa patogene bishobora kuba 200Copies / mL.
● Kugereranya agaciro ka CV
| Gusubiramo icyitegererezo cyo gusohora | ||
| kwibanda: 5000Copi / mL | ORF1ab | N |
| 30.17 | 30.38 | |
| 30.09 | 30.36 | |
| 30.36 | 30.26 | |
| 30.03 | 30.48 | |
| 30.14 | 30.45 | |
| 30.31 | 30.16 | |
| 30.38 | 30.7 | |
| 30.72 | 30.79 | |
| CV | 0,73% | 0,69% |
Iyo bipimishije kuri kopi 5.000 / mL, CV ya orFab na N yari 0,73% na 0,69%.
